Profile data is unavailable for this security.
About the company
Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients and corporate clients, including chemical pathology, hematology, histopathology & cytopathology, serology & microbiology, allergy & immunology, molecular cancer testing, genetic carrier screening & other antenatal testing, cardiac testing services, veterinary pathology, functional pathology, and pathology services for clinical trials, among others. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory. Its SunDoctors brand provides skin cancer care services.
- Revenue in AUD (TTM)741.27m
- Net income in AUD32.43m
- Incorporated2020
- Employees4.70k
- LocationAustralian Clinical Labs Ltd1868-1892 Dandenong Road, ClaytonMELBOURNE 3168AustraliaAUS
- Phone+61 30045-3688
- Websitehttps://www.clinicallabs.com.au/
Mergers & acquisitions
| Acquired company | ACL:ASX since announced | Transaction value |
|---|---|---|
| Healius Ltd | -29.12% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apiam Animal Health Ltd | 206.92m | 832.00k | 160.98m | -- | 230.77 | 1.32 | 11.82 | 0.778 | 0.0038 | 0.0038 | 1.11 | 0.6613 | 0.809 | 4.57 | 15.75 | -- | 0.3378 | 1.65 | 0.3896 | 1.93 | 66.22 | 63.46 | 0.4175 | 1.97 | 0.5026 | 2.33 | 0.4586 | 71.37 | 1.11 | 11.83 | -83.13 | -27.29 | 27.96 | 0.3129 |
| Eureka Group Holdings Ltd | 45.79m | 20.06m | 211.16m | 42.00 | 9.78 | 0.8739 | 10.28 | 4.61 | 0.0506 | 0.0506 | 0.1189 | 0.5664 | 0.1506 | -- | 206.26 | -- | 6.60 | 6.12 | 6.75 | 6.29 | 54.76 | 52.75 | 43.81 | 37.02 | -- | -- | 0.1908 | 30.22 | 11.30 | 13.04 | 51.90 | 19.90 | 21.25 | 6.71 |
| Monash IVF Group Ltd | 271.92m | 25.01m | 270.80m | 892.00 | 10.90 | 1.10 | 5.68 | 0.9959 | 0.0638 | 0.0638 | 0.6947 | 0.6321 | 0.5433 | 3.43 | 9.15 | 304,839.70 | 5.13 | 4.12 | 6.32 | 4.84 | 89.16 | 89.42 | 9.44 | 7.69 | 0.5321 | 6.08 | 0.4182 | 95.49 | 6.65 | 13.34 | 483.15 | 16.36 | 13.96 | 5.80 |
| Australian Clinical Labs Ltd | 741.27m | 32.43m | 524.76m | 4.70k | 15.69 | 3.10 | 3.11 | 0.7079 | 0.174 | 0.174 | 3.90 | 0.8812 | 1.27 | 7.90 | 10.16 | 157,716.80 | 5.62 | 12.05 | 8.84 | 18.53 | 82.70 | 81.44 | 4.43 | 8.79 | 0.4826 | 4.88 | 0.628 | 55.61 | 6.45 | 8.61 | 35.50 | -4.70 | -2.16 | -- |
| Artrya Ltd | 28.00k | -16.41m | 534.32m | -- | -- | 18.00 | -- | 19,083.00 | -0.1782 | -0.1782 | 0.0003 | 0.1878 | 0.0013 | -- | 0.006 | -- | -76.86 | -50.54 | -84.04 | -53.79 | -- | -- | -58,592.86 | -224,202.80 | -- | -- | 0.0285 | -- | -- | -- | -17.19 | -- | 76.21 | -- |
| Australian Unity Ltd | 2.56bn | 29.28m | 577.02m | 7.70k | -- | -- | 5.65 | 0.2253 | -- | -- | -- | -- | 0.2504 | -- | -- | -- | 0.2863 | 0.2535 | -- | -- | -- | -- | 1.14 | 1.08 | -- | 2.32 | 0.3517 | -- | 19.22 | 12.82 | 225.85 | 26.26 | -3.12 | -- |
| Healius Ltd | 1.34bn | -563.00m | 668.04m | 8.00k | -- | 1.14 | -- | 0.497 | -0.7754 | -0.2082 | 1.85 | 0.8096 | 0.5648 | 6.94 | 7.21 | 168,025.00 | -23.66 | -7.07 | -30.32 | -8.67 | 84.08 | 85.70 | -41.88 | -14.73 | 0.4978 | 0.0031 | 0.608 | -- | 5.69 | -2.90 | 15.97 | -- | -7.13 | -- |
| Integral Diagnostics Ltd | 627.22m | 4.67m | 928.59m | 3.03k | 207.67 | 1.34 | 15.13 | 1.48 | 0.012 | 0.012 | 2.02 | 1.86 | 0.5779 | 13.49 | 23.69 | 207,343.80 | 0.444 | 0.3746 | 0.4959 | 0.4202 | 95.52 | 95.19 | 0.7683 | 0.668 | 0.6595 | 2.13 | 0.4574 | 568.89 | 33.70 | 17.91 | 107.70 | -27.31 | 18.22 | -7.07 |
| Regis Healthcare Ltd | 1.16bn | 48.95m | 2.01bn | 11.00k | 41.34 | -- | 20.39 | 1.73 | 0.1611 | 0.1611 | 3.82 | -0.0555 | 0.5928 | -- | 46.38 | -- | 2.50 | -0.2222 | -- | -2.22 | -- | -- | 4.22 | -0.4523 | -- | -- | -- | -- | 14.52 | 11.37 | 328.58 | -- | 17.09 | 32.18 |
| Holder | Shares | % Held |
|---|---|---|
| Allan Gray Australia Pty Ltd.as of 22 Sep 2025 | 32.83m | 17.08% |
| Colonial First State Investments Ltd.as of 11 Sep 2025 | 14.31m | 7.45% |
| Superannuation Funds Management Corp. of South Australiaas of 11 Sep 2025 | 14.11m | 7.34% |
| First Sentier Investors RQI Pty Ltd.as of 15 Oct 2025 | 11.14m | 5.79% |
| Vinva Investment Management Ltd.as of 26 Sep 2025 | 10.13m | 5.27% |
| Investors Mutual Ltd.as of 26 Sep 2025 | 9.96m | 5.18% |
| Australian Ethical Investments Ltd. (Investment Management)as of 21 Jan 2026 | 9.57m | 4.98% |
| Yarra Funds Management Ltd.as of 02 Oct 2024 | 9.46m | 4.92% |
| Regal Funds Management Pty Ltd.as of 06 Aug 2025 | 8.95m | 4.66% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 7.00m | 3.64% |
